Home / Drug shortages / Palonosetron Hydrochloride Injection

Palonosetron Hydrochloride Injection — FDA Drug Shortage

To Be Discontinued — Teva Pharmaceuticals USA, Inc.

The FDA lists a drug shortage record for Palonosetron Hydrochloride Injection (injection) from Teva Pharmaceuticals USA, Inc. with status To Be Discontinued. The shortage was first posted on 11/14/2025.

Shortage Details

Status
To Be Discontinued
Company
Teva Pharmaceuticals USA, Inc.
Package NDC
0703-4094-01
Dosage Form
Injection
Presentation
Palonosetron Hydrochloride, Injection, .25 mg/5 mL (NDC 0703-4094-01)
Initial Posting
11/14/2025
Revised Date

FDA data resources